The enclosed peer-reviewed journal article is provided in the interest of free exchange of truthful scientific information. Restore ® wound care dressings* are intended for single use in the management of partial-and full-thickness wounds.
D
ressing selection should have the main objectives of promoting and maintaining a favourable environment to facilitate healing (Eaglstein and Falanga, 1997) . Most of the published clinical data support the use of dressings that promote microenvironmental factors, such as optimal oxygen tension, pH and humidity, which stimulate more rapid wound healing, in particular those that support a moist wound environment. In addition, the choice of dressing will be influenced by clinical factors, such as the type of wound, position, presence of debris or infection, level of exudate and patient comfort.
Further, an optimal wound dressing should meet the following criteria: n Maintain a moist environment at the wound/dressing interface n Remove excess exudate n Have thermal insulation properties n Allow gaseous exchange n Be impermeable to bacteria, in and out of the wound environment n Be free of particles and toxic wound contaminants n Permit trauma and pain-free removal (Dealey, 1993) .
Taking into account the fact that wound healing takes place in three phases (inflammation, tissue formation, and tissue remodelling) that overlap in time, it is unlikely that any one dressing will have an optimal performance for all of these stages (Singer and Clark, 1999) .
The categories of modern wound dressings broadly include films, foams, hydrocolloids and alginates. Foams and alginates are generally appropriate for wounds with a significant amount of exudate (Morgan, 1996; Schultze et al, 2001) . Hydrocolloids are designed for wounds with mild to moderate drainage. Films are used in superficial wounds with minimal drainage (Choucair and Phillips, 1998; Bradley et al, 1999; Briggs, 2000) .
When granulation tissue is present, exudate levels low, and re-epithelization of wound underway these dressings may not be totally appropriate. In this instance, nonadherent silicone or perforated plastic film dressings, or petrolatum gauze are often used (Williams, 1995; Thomas, 1997; Dealey, 2000) .
Such gauzes are regarded as hypoallergenic dressings; they act as interfaces that cling and conform to the wound without adherence. However, in practice this is not always the case (Thomas, 1990; ; because of the physiologically inert nature of petrolatum they can be used on any wound, acute or chronic.
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Nevertheless, owing to their non-existent absorbency, secondary absorbent dressings may be required. Currently, such impregnated gauze dressings are widely used in burns therapy and acute wounds, and to a lesser extent in the treatment of chronic wounds (Lawrence, 1993; Williams, 1995; Dealey, 2000) .
In order to combine desirable properties of hydrocolloids with those of petrolatum gauze, a new generation of dressing has been developed, the lipidocolloid dressings. The first representative of this new class of dressing is Urgotul® each evaluation the general appearance of the wound, surface area and dressing tolerability (i.e. signs of local erythema, pain, maceration, malodour, bleeding, infection) were recorded.
After the inclusion of 72 patients with acute or chronic wounds, the trial was extended to include partial-thickness burns. Seven burn units participated in the extension of this study. Patients with clean, non-infected second-degree burns of less than 200cm2 area, and any origin or location, were enrolled.
At the inclusion visit the general appearance of the lesion and planimetry were recorded. Urgotul® was applied after usual lesion cleansing (Figure 2 ). Patients were then seen on a (Urgo, France). The characteristics of this material appear to be particularly adapted to the treatment of the granulation and re-epithelization stages of the healing process, both in acute and chronic wounds (Benbow, 2002; Dumas and Meaume, 2000; Pannier et al, 2000) .
Urgotul ® : a new non-adherent petrolatum and hydrocolloid impregnated dressing
Urgotul® is composed of a 100% polyester crosswise open weave impregnated with hydrocolloid polymers dispersed within a petrolatum impregnated mesh. Its macroscopic aspect is that of a non-greasy light and soft gauze which adapts itself easily to wound shape (Figures 1a and 1b) . Urgotul® will not fray, so no microfibres will be released into the wound.
In contact with exudate, hydrocolloid polymers are hydrated and constitute with the petrolatum part of the dressing, a lipidocolloid interface which is designed to reduce adhesion to the wound surface. Urgotul® has an appreciable fluid absorbtive capacity.
The lipidocolloid interface is very cohesive, preventing release of petrolatum on to the wound surface and facilitating dressing removal. In addition, the open weave of the polyester is non-deformable and maintains the 500µm size when impregnated, thus reducing the growth of granulation tissue growing through and the consequent risk of trauma on removal. This dressing maintains a pH of 6.5-7.5, according to the wound environment.
Urgotul® is indicated for the treatment of superficial acute or chronic exuding wounds at the granulation and re-epithelization stages of the healing process. It is a nonadherent primary wound contact layer that should usually be changed every 2-3 days, but can be left in place for longer (6 days) on low or lightly exuding wounds. As a result of the low adherence to the wound, painfree and non-traumatic (no bleeding) removal are to be expected (Moody, 1992; Hollinworth, 1995; Williams, 1996) . In practice, this has been found to be the case (Benbow, 2002) 
Clinical experience with Urgotul ® Methods
The efficacy and safety of Urgotul® were evaluated in a multicentre non-controlled clinical trial involving a total of 92 patients followed up to healing or up to 4 weeks. This trial was approved by the relevant ethics committees and written agreement obtained before the start of treatment.
Patients aged 18 years or over, with acute (duration of wound ≤28 days) or chronic (duration >28 days) wounds were included by 20 centres in France. Only clean/debrided wounds of surface area less than 100cm2, without signs of infection, and of any aetiology except cancerous lesions, were included.
At the inclusion visit, a complete patient history was recorded, clinical evaluation of the wound performed, including photograph and planimetry measurement, and the first Urgotul® dressing was applied after cleansing the wound with physiological saline.
Thereafter, patients were seen at least once per week for evaluation or more often for dressing changes, as required. At weekly basis up to healing or up to 4 weeks for evaluations or more often, as required, for dressing changes. At each visit, surface area and dressing conformability, adhesion and tolerability were recorded.
Data from all 92 patients enrolled were included in the descriptive analysis. The progress of wound surface area over the 4-week follow-up period (digitized from the tracings by planimetry) was calculated with the last observed value carried over. Tolerability and local or general adverse events were descriptively reported. No statistical tests were performed. Results are presented as means or percentages.
Results Patients
Seventy-two patients with acute or chronic wounds (excluding burns) were enrolled in the first part of the trial ( Table 1) . The main baseline characteristics of these subjects are presented in Table 1 . Fifty-four per cent (n=39) of the patients were females. The mean age of the population ranged 68-73 years. Thirty-four wounds were acute with a mean duration of 10.2 days; these were mainly of a traumatic or postoperative aetiology and were located on the lower limbs in most cases. Their mean baseline surface area was 19.1±(SD) 21.0cm2.
Among the 38 chronic wounds, 24 were leg ulcers (venous or arterial; mean baseline area: 19.1±35.5cm2) and were present for 9.6 months on average (in one case a 2-day-old recurrent venous ulcer was classified as a chronic wound). The other 14 chronic wounds (mean duration of 3.2 months, mean baseline surface area 10.3±7.2cm2) were principally pressure ulcers (five cases) or amputation stump wounds (four cases). On inclusion 25% and 50% of acute and chronic wounds were in turn completely covered with granulation tissue.
In the series of burned patients (Table 2) , 20 subjects with partial-thickness second-degree burns were included. Their mean age was 39.5 years. They were seen on average 2.3 days after the injury. The site of the burn was mainly the lower limbs and the hands.
Drop-outs
Fifteen patients (20.8%) out of the 72 first included patients dropped out ( Table 3) . Main reasons for this were hospitalization (four cases) and need for skin grafting (four cases). The remainder dropped out for other unrelated reasons. Occurrence of a local adverse event or wound deterioration were reported in two and three patients respectively. One dropout was reported in the 20 burned patients. In this patient a partial necrotic zone appeared at treatment day 20 and the continued use of Urgotul® was regarded as clinically inappropriate.
Healing rate
In the first part of the study, 16 wounds (22.2%) healed before the end of the 4-week follow-up period. The percentage of patients who healed in this period was 32.4%, 12.5% and 14.3% respectively in the acute wounds, leg ulcers and other chronic wounds (see Table 3 ).
Compared with baseline values, surface areas decreased on average by 76.4%, 63.5% and 44.2% respectively at study end point in the acute, leg ulcers and chronic lesions.
Regarding the burned lesions, 19 patients healed (95.0%) during the course of the study. Complete healing was obtained within 5-19 days (11.0±4.5days on average).
Dressing changes
In the first part of the study, 771 dressing changes were performed (Table 4); this was approximately 11 changes per wound. Urgotul® was changed every 2-2.3 days on average but was left in place in some cases from 5-10 days. Dressing application was considered as 'easy' or 'very easy' in over 90% of the changes and no instance of 'difficult to remove' recorded. Dressing changes were generally painless and maceration not observed. The conformability of the dressing to the wound shape was considered as appropriate in almost all of the acute wounds and less often in chronic wounds (poor conformability noted in 11% and 14% of the changes respectively). No or slight adhesion of the dressing was observed in more than 90% of dressing changes.
In the burns group, 97 dressing changes were conducted. Dressing application and removal were considered as 'easy' or 'very easy' in 81% and 79% respectively of the changes. The wear time ranged from 2-5days (mean 2.5 days). As anticipated, dressing changes were less frequently reported as painless compared with the acute and chronic wounds. Conformability was considered 'very good' in 62% of the cases (the remaining 38% where conformability was less were especially burns located on the fingers). No adherence of the dressing to the wound was noticed in 67% of the cases.
Local tolerability
In ulcers, acute and chronic wounds, a total of seven local adverse events (Table 5) were recorded in seven patients (7.6% of the total population). Three of these patients were treated for an acute wound. In two cases only, the occurrence of periwound erythema was the reason to stop the study dressing. In chronic wounds, one extension of ulceration of the wound edges was observed in a patient treated for an amputation stump wound, and a transitory overgranulation was noted in a post-traumatic wound. For the other events there was no causal relation to Urgotul®.
In two patients (10.0%) out of the 20 treated for seconddegree burns, a local adverse event was reported, considered by the investigators as 'probably' related to the dressing. This was a slightly painful and transitory inflammatory reaction in one case and a painful removal of the dressing on one occasion in the other. Otherwise, these two events did not justify the stopping of Urgotul® application.
Discussion and Conclusions
It is vitally important that the delicate newlyformed tissues that appear in wounds undergoing granulation and re-epithelization are protected from trauma. Since the development of tulle gras in the early 20th century there have been many dressing developments for superficial or partial-thickness wounds. Not all of these have been successful as non-adherent and painfree products (Williams, 1996; Schultze et al, 2001 ). There is a need for a dressing that can remain in place, without adhering, and be painfree and non-traumatic on removal in the treatment of burns, fixation of grafts, abrasions, and chronic wounds. Urgotul® is the first of a new generation of wound dressing, the lipidocolloid dressings. It is an interface (wound contact layer) dressing well designed to treat acute or chronic wounds at their granulation and reepithelization stages.
This clinical study was aimed at evaluating the tolerability of this new material in various types of wounds and anatomical location. A total of 92 patients were treated over 4weeks for second-degree burns, acute wounds, and leg ulcers or other chronic wounds. A total of 868 dressing changes were conducted. Ease of dressing application and removal were rated as 'excellent' in most of the cases; the dressing did not promote maceration, bleeding or pain. Its conformability to the shape of the wounds was generally good and inappropriate adhesion of the dressing was regarded as a problem in only a single instance.
While this study was not designed to evaluate healing rate, the data collected over a 4-week treatment period are nonetheless encouraging. Urgotul® constitutes a highly promising new generation of dressing which merits further clinical evaluations. n Preliminary clinical trial data show Urgotul® to be safe and effective on partial-thickness burns, and a variety of acute and chronic wounds.
n The combination of hydrocolloid polymers and petrolatum gives the dressing its specific properties and represents an alternative to conventional or modern wound dressings.
n Further comparative clinical trials are underway to establish the relative effects of the Urgotul® dressing on the healing process. Hollister Wound Care LLC has the non-exclusive license to produce, print, publish this article and all parts, adaptations and abridgements thereof in all forms of media, including electronic rights in all languages and territories throughout the universe for a period of one year
